Medical Letter on the CDC and FDA

Cardiovascular Disease - Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter

Cardiovascular Disease - New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease

Cervical Disease - Study Finds New Version of QIAGEN's HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment

Chronic Kidney Failure - Amgen Announces Updates to the U.S. Prescribing Information for ESAs

Coagulation - Osmetech Licenses Warfarin Biomarker from Marshfield Clinic

Depression - Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder

Drug Development - Watson Files FDA Application for Generic YAZ(R)

Drug Safety - Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings

Emerging Disease - Training Medical Warriors: Tropical Medicine Specialists Who Ward Off Bioterrorist and Global Health Threats Pass the Torch to the Next Generation

Erectile Dysfunction - Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction

Financials - Adams Respiratory Therapeutics Reports Fiscal 2008 First Quarter Results

Flu Vaccines - Free Flu Vaccinations Provided for Fire-Afflicted San Diego Residents

Graft-Versus-Host Disease - FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation

Graft-Versus-Host Disease - First Patient Undergoes Expanded Cord Blood Transplant in the ExCell Registration Study of StemEx(R) for Leukemia and Lymphoma

Heart Attack - Abbott Confirms FDA Advisory Panel to Review XIENCE(TM) V Drug Eluting Stent on November 29

Heart Attack - Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium

Heart Attack - Reported to the American Heart Association Scientific Sessions: Newly Discovered Heart Wall Abnormality May Predict Risk of Stroke Associated with Patent Foramen Ovale, AGH Cardiologists Report

Hepatocellular Cancer - CELSION Provides Update on Status of Special Protocol Assessment (SPA) Submission

HIV/AIDS - StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA

Homeland Security - Emergent BioSolutions Announces Update on Department of Defense Procurement Strategy for BioThrax(R) (Anthrax Vaccine Adsorbed)

Managed Care - CollaGenex Pharmaceuticals Reports Financial Results for the Third Quarter of 2007

Mental Health - Musculoskeletal Clinical Regulatory Advisers, LLC Expands Reimbursement Department

Mental Illness - U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia

Metastatic Cancer - FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.

Neurological Disease - Cenomed BioSciences Co-Awarded Chemical Defense Grant by JSTO-CBD/DTRA to Evaluate the Use of Novel Compounds to Enhance the Effectiveness of Currently Used Nerve Agent Treatments

Non-Hodgkin Lymphoma - Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results

Pediatrics - Bayer HealthCare Pharmaceuticals, HealthTrust Purchasing Group Sign a Three-Year Renewal Agreement for Magnevist(R) Magnetic Resonance Contrast Media

Pediatrics - FDA Selects Premier Healthcare Alliance as Source for Inpatient Drug Data

Pediatrics - Tweens Double Use of Diabetes Drugs

Phenylketonuria - MAA Submitted to EMEA for European Marketing Authorization of Sapropterin for Hyperphenylalaninemia (HPA)

Protein Therapies - VistaGen Awarded $1.2 Million from NIH for Development of AV-101 for Neuropathic Pain, Parkinson's Disease and Epilepsy

Public Health - Study shows energy drink 'cocktails' lead to increased injury risk

Regulatory Actions - Bard Receives Clearance to Market Agento(TM) IC Silver-Coated Endotracheal Tube

Regulatory Actions - Bayer Temporarily Suspends Global Trasylol(R) Marketing

Regulatory Actions - CDISC Crossing the Chasm: Significant Growth Announced in Use of CDISC Standards

Regulatory Actions - eyeonics Ranked 113th Fastest Growing Company in North America on Deloitte's 2007 Technology Fast 500

Regulatory Actions - Innovative Amerathon Club Website 'Virtual' Journey to Good Health

Renal Disease - Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients

Smallpox Vaccines - Bavarian Nordic Vaccine Programs Progressing as Planned

Terrorism - EyeMarker Systems Named Finalist in Global Security Challenge

Veno-occlusive Disease - Gentium Provides Clinical Update on Phase III Defibrotide Clinical Program

Weight Management - Healthways and GlaxoSmithKline Consumer Healthcare Collaborate on Behavioral Support for Weight Control, Smoking Cessation